US & China Asthma and COPD Drugs Market - PowerPoint PPT Presentation

About This Presentation
Title:

US & China Asthma and COPD Drugs Market

Description:

TMR’s US & China Asthma and COPD Drugs Market market report helps analyze trends and significant developments in the industry. In addition, it also provides insights predicting growth rates of the US & China Asthma and COPD Drugs Market market using detailed assessment of key drivers, threats, restraints, along with opportunities that are likely to open doors for growth in coming years. For More Technical Insights, Download Brochure @ – PowerPoint PPT presentation

Number of Views:24

less

Transcript and Presenter's Notes

Title: US & China Asthma and COPD Drugs Market


1
Asthma is a disease characterized by recurrent
attacks of coughing, chest-tightening,
breathlessness, and wheezing as the airways
narrow and swell that vary in severity and
frequency. COPD is a disease of the lungs
characterized by obstruction to airflow that
interferes with normal breathing. .
US China Asthma and COPD Drugs Market
2
U.S. and China Asthma and COPD Drugs Market
Snapshot
  • The U.S. and China market for asthma and chronic
    obstructive pulmonary disease (COPD) drugs is
    expected to exhibit growth at a steady pace in
    the next few years. Factors such as a significant
    rise prevalence of COPD and asthma in these two
    countries, advancements in diagnostic methods,
    and rising awareness among patients regarding the
    available treatment methods are considered key to
    the overall growth of the market over the period
    20162024.
  • The market is expected to exhibit growth at a
    moderate pace in the first few years of the
    forecast period, chiefly owing to the patent
    expiries of leading drugs and the subsequent
    price erosion. However, the market is expected to
    witness new drug candidates by 2020, which will
    help the market tread along a better growth path
    in the forthcoming years.
  • Transparency Market Research estimates that the
    market will exhibit a 4.1 CAGR from 2016 through
    2024, rising to a valuation of US18.7 bn by 2024
    from US13.0 bn in 2015.

3
(No Transcript)
4
Table of Content
Sr. No. Content
Chapter1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary
Chapter 4 Market Overview
Chapter 5 U.S. and China Asthma and COPD Drugs Market Analysis and Forecast, By Drug Class
Chapter 6 U.S. and China Asthma and COPD Drugs Market Analysis and Forecast, By Indication
Chapter 7 U.S. and China Asthma and COPD Drugs Market Analysis and Forecast, By Region
Chapter 8 U.S. Asthma and COPD Drugs Market Analysis and Forecast
Chapter 9 China Asthma and COPD Drugs Market Analysis and Forecast
Chapter 10 Competition Landscape





Access Full TOC
5
Report Highlights
  • Transparency Market Research estimates that the
    US China Asthma and COPD Drugs Market will
    exhibit a 4.1 CAGR from 2016 through 2024,
    rising to a valuation of US18.7 bn by 2024 from
    US13.0 bn in 2015
  • Some of the leading vendors presently operating
    in the U.S. and China asthma and COPD drugs
    market profiled in the report are Boehringer
    Ingelheim, GlaxoSmithKline plc, Merck and Co.,
    Inc., Novartis AG, AstraZeneca plc, and F.
    Hoffmann-La Roche.

Request Sample of Report
6
About Us
  • Transparency Market Research (TMR) is a market
    intelligence company, providing North America
    business information reports and services. Our
    exclusive blend of quantitative forecasting and
    trends analysis provides forward-looking insight
    for thousands of decision-makers. We have an
    experienced team of Analysts, Researchers, and
    Consultants, who use proprietary data sources and
    various tools and techniques to gather and
    analyze information. Our business offerings
    represent the latest and the most reliable informa
    tion indispensable for businesses to sustain a
    competitive edge.
  • Each TMR Syndicated Research report covers a
    different sectorsuch as pharmaceuticals,
    chemical, energy, food beverages,
    semiconductors, med-devices, consumer goods, and
    technology. These reports provide in-depth
    analysis and deep segmentation to possible micro
    levels. With a wider scope and stratified
    research methodology, our syndicated reports
    strive to serve clients and satisfy their overall
    research requirement.

7
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com